Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$GVH - Globavend Holdings Limited Enters Into a US $20,000,000 Equity Line of Credit Facility to be Registered on Form F-1 https://finance.yahoo.com/news/globavend-holdings-limited-enters-us-074200855.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance #news #funding
$NRXP $4.88 HOD $5.25! NRX-100/NRX-101: We are studying Suicidal Treatment Resistant Bipolar Depression https://www.reddit.com/r/nasdaq/comments/1bu0sil/nrxp_488_hod_525_nrx100nrx101_we_are_studying/?utm_source=share&utm_medium=web2x&context=3
#News $GDHG (Nasdaq) Enters into a Collaboration Agreement with Nanping City Dacheng Culture Communication Ltd
Mr. Jin Xu, CEO of GDHG "Our collaboration agreements are designed to leverage our park locations & family-oriented attractions, enhance site utilization & strengthen bonds with guests"
For more information, please visit the Company's website at https://ir.jsyoule.com/.
#News GDHG Enters into a Collaboration Agreement with Nanping City Dacheng Culture Communication Ltd
— Golden Heaven Group Holdings Ltd. (@GoldenHeavenLTD) April 2, 2024
Mr. Jin Xu, CEO "Our collaboration agreements are designed to leverage our park locations & family-oriented attractions, enhance site utilization & strengthen bonds with guests" pic.twitter.com/4oyjXDJfiT
$IVDN: We love to see photos like this of the Lindus team installing our patented Insultex House Wrap (TM) which gives customers the highest energy efficiency to lower both heating and cooling bills with its unmatched R-6 rating. Learn more at: https://t.co/LWNDwJcXDh
$IVDN: We love to see photos like this of the Lindus team installing our patented Insultex House Wrap (TM) which gives customers the highest energy efficiency to lower both heating and cooling bills with its unmatched R-6 rating. Learn more at: https://t.co/LWNDwJcXDh
— Innovative Designs, Inc (Stock: $IVDN) (@riccelli_joseph) April 2, 2024
$TREIF cse: $TRUE Treatment AI is quickly becoming the best assistant a doctor or nurse could ever ask for https://www.reddit.com/r/stockstobuytoday/comments/1btaegp/treif_cse_true_treatment_ai_is_quickly_becoming/
$EFSH looks primed $90m in revenues FY 2023 with spinoff/dividend in play. Tiny float 5.9m https://mailchi.mp/broadstreetalerts/efsh-breakout-alert-95653?e=
$IVDN Insultex™ is a revolutionary structured cellular fabric that incorporates countless evacuated closed micro-cells that significantly reduce heat transfer through the fabric.
https://insultexhousewrap.com
$AVRW (OTCQB) Media Grabbing Seratopical Revolution Skin Care Line, Personal Choice of Nicole Kidman for Years, Now Directly Recommended by LeadingLA Plastic Surgeon for Superior Anti-Aging Results
https://news.columbusnewsonline.com/story/478529/media-grabbing-seratopical-revolution-skin-care-line-personal-choice-of-nicole-kidman-for-years-now-directly-recommended-by-leadingla-plastic-surgeon-for-superior-antiaging-results-avrw.html?utm_source=dlvr.it&utm_medium=twitter
$IQST has been skyrocketing lately. Everyone thinks it's going to a billion dollars in revenue and will hit NASDAQ at two bucks.
https://www.prnewswire.com/news-releases/iqst--iqstel-announces-55-annual-revenue-growth-to-over-144-million-302104595.html
NASDAQ: $GDHG $NRXP $RENB -Sending the Bears back into Hibernation with these 3 potential Short Squeeze Stocks
https://www.einpresswire.com/article/696925899/sending-the-bears-back-into-hibernation-with-these-3-potential-short-squeeze-nasdaq-stocks via @ein_news
$GEVI General Enterprise Ventures, Inc. (OTC:GEVI), Subsidiary Mighty Fire Breaker (MFB) Has Published Its Wildfire Defense System Course approved by the AIA and USGB Council through AEC Daily Corporation for Continuing Education Credits
https://finance.yahoo.com/news/general-enterprise-ventures-inc-otc-130000212.html
$NRXP $0.485 $0.0131 (2.78%)
$NRXP News: NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PR Newswire
Mon, Apr 1, 2024, 8:28 AM EDT15 min read
In This Article:
NRXP; NRXPW
Four potential near-term milestones, including data from two clinical trials, an NDA filing and an upcoming share dividend
RADNOR, Pa., April 1, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced its financial results for the quarter and year ended December 31, 2023 and provided a business update.
https://finance.yahoo.com/news/nrx-pharmaceuticals-nasdaq-nrxp-reports-122800953.html
$ACGX NEWS: Alliance Creative Group (ACGX) Releases 2023 Annual Financial and Disclosure Report - PeopleVine's revenue increased by 100% in 2023 https://finance.yahoo.com/news/alliance-creative-group-acgx-releases-120000840.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance @ACGpaul #BreakingNews @frontpagestocks
$GDHG -Golden Heaven Group Holdings Ltd. Enters into a Collaboration Agreement with Zigong City Dragon Culture & Arts Co Ltd. https://prn.to/3TD80Jj $MSFT $HOOD $FSR $DKS $PATH $LAC $UA $S $UAA $SOUN $APM $X $CMG $WIMI $CCTG $SOFI $BUD $RIVN $PWDY $SPY $QQQ $AMZN $CWIF
$AVRW Amazon Store - Indulge Your Skin With Seratopicals #OTCQB
https://www.amazon.com/stores/SERATOPICAL/Homepage/page/473637CB-F4D4-470C-B60D-7B3885CDED6E?lp_slot=auto-sparkle-hsa-tetris&store_ref=SB_A04197472SH5XD3NMXT7L-A08646773CQFBV70N5Y1K&ref_=cm_sw_r_ud_ast_store_C2NDJSDGTZ9HT4QH9A4D #Amazon.com
$NRXP NRx Pharmaceuticals, Inc. Planned Public Stock Dividend, Royalty Rights Pledged to Shareholders for Valuable Ketamine Franchise: NASDAQ: NRXP https://www.einpresswire.com/article/696916460/planned-public-stock-dividend-royalty-rights-pledged-to-shareholders-for-valuable-ketamine-franchise-nasdaq-nrxp via @ein_news For more information on $NRXP visit: https://www.nrxpharma.com/ and https://axecapitalusa.com/nrxp/
$RENB GEDiCUBE Intl Ltd. A wholly owned subsidiary of NASDAQ: RENB announces it has executed a binding Letter of Intent (LOI) to acquire 75% of Cyclomics Renovaro Biosciences Inc. https://www.einpresswire.com/article/688313019/renovaro-biosciences-inc-collaborates-with-nvidia-partner-gedicube-for-advanced-cancer-diagnosis-nasdaq-renb @ein_news
$GRTX $JANX $ZVSA $ADN $IFBD $PUBM $SRFM $TMDX $HOLO $AKLI $BSGM
$IQST - iQSTEL has been exploding lately. Huge volume, new buyers coming in everybody is excited about the new acquisition. Headed towards a billion-dollar revenue! BUY!
$GDHG - Our portfolio spans a range of attractions from thrilling rides to family-friendly entertainment, ensuring broad appeal to a wide audience. Together, let's chart a course towards a future filled with growth, profitability, and boundless excitement. @Nasdaq
#amusementparks #profitable #investors
$DIS $SEAS $SIX $FUN $CMCSA $GDHG https://www.instagram.com/p/C5D1csvgPUW/
$NRXP News: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) today announces its anticipated financial results for the quarter and year ended December 31, 2023.
Read More - https://ir.nrxpharma.com/2024-03-28-NRx-Pharmaceuticals-NASDAQ-NRXP-Reports-Preliminary-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Year-End-Highlights
#NRxPharma #PharmaNews #NRX100 #NRX101 $NRXP
$IVDN: We are working with an increasing number of customers to supply our R-6 rated Insultex House Wrap (TM) that advances the green building goal of higher energy efficiency. A patented evacuated cell design far outperforms all competition. Visit: http://insultexhousewrap.com
$IVDN: We are working with an increasing number of customers to supply our R-6 rated Insultex House Wrap (TM) that advances the green building goal of higher energy efficiency. A patented evacuated cell design far outperforms all competition. Visit: https://t.co/LWNDwJcXDh https://t.co/pfpi5mswzp pic.twitter.com/hcouPP9Pqh
— Innovative Designs, Inc (Stock: $IVDN) (@riccelli_joseph) March 28, 2024
$AVRW Amazon Store - Indulge Your Skin With Seratopicals #OTCQB
https://www.amazon.com/stores/SERATOPICAL/Homepage/page/473637CB-F4D4-470C-B60D-7B3885CDED6E?lp_slot=auto-sparkle-hsa-tetris&store_ref=SB_A04197472SH5XD3NMXT7L-A08646773CQFBV70N5Y1K&ref_=cm_sw_r_ud_ast_store_C2NDJSDGTZ9HT4QH9A4D #Amazon.com
$RENB #AI Pioneer GEDiCube/ RenovaroCube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine https://renovarobio.com/news/ai-pioneer-gedicube-and-biotech-innovator-renovaro-biosciences-combine-forces-to-accelerate-personalized-medicine/ $TXN $TQQQ $AIQ $SPDR $NET $AI $META $MSFT $AAPL $TSLA #AI #Healthcare $ADBE $GOOGL $BIDU $IBM $MU
$NRXP #Update Due to scheduling conflicts and Good Friday stock market holiday, NRx Pharmaceuticals will now host its conference call to discuss the financial results and corporate update on Monday, April 1, 2024, at 8:30 a.m. ET. https://ir.nrxpharma.com/index.php?s=43&item=223
Due to scheduling conflicts and the Good Friday stock market holiday, NRx Pharmaceuticals will now host its conference call to discuss the financial results as well as provide a corporate update on Monday, April 1, 2024, at 8:30 a.m. ET.
— NRx Pharmaceuticals (@NRxPharma) March 27, 2024
Read More - https://t.co/c3MQToYP5X
$IVDN Insultex™ is a revolutionary structured cellular fabric that incorporates countless evacuated closed micro-cells that significantly reduce heat transfer through the fabric. https://insultexhousewrap.com
$GDHG #undervalued here. Great company on @Nasdaq
New Tweet!! GDHG -Dedicated to Innovation and Excellence, constantly seeking new ways to enhance Our visitor experience and drive Sustainable Growth. Invest in Golden Heaven Group and be a part of something extraordinary. @nasdaq https://ir.jsyoule.com
$SIX $DIS $GDHG $FUN #Global #Growth
GDHG -Dedicated to Innovation and Excellence, constantly seeking new ways to enhance Our visitor experience and drive Sustainable Growth. Invest in Golden Heaven Group and be a part of something extraordinary. @nasdaq https://t.co/o6KKIHgysk $SIX $DIS $GDHG $FUN #Global #Growth pic.twitter.com/rTO4DHlEi0
— Golden Heaven Group Holdings Ltd. (@GoldenHeavenLTD) March 27, 2024
$NRXP .55 +6.59% UPDATE OUT: NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024 https://finance.yahoo.com/news/nrx-pharmaceuticals-nasdaq-nrxp-report-200300524.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via Yahoo Finance #news #update
$AVRW The patent-pending deep nano actives in DNA Complex encapsulates a proprietary blend of anti-aging ingredients that are carried far beneath the layers of the skin. @avenirwellness @sera_labs https://seralabshealth.com/pages/introducing-dna-complex #OTCQB
$NRXP is solid and holding very well, and once the shorts are out of bullets we will squeeze them as hard as 100-300%+ a day. Stock Dividend & Share Structure Reduction to Counter Short Selling and Boost Institutional Investment: NASDAQ: NRXP https://lnkd.in/euxNXy2g
$GDHG -"Investing in GDHG means investing in unforgettable experiences for millions of visitors, where joy meets financial prosperity in the world of entertainment."
#amusementparks #thrills #rides #familytime #profitable #investment
@nasdaq
$DIS $SEAS $SIX $FUN $GDHG
GDHG -"Investing in GDHG means investing in unforgettable experiences for millions of visitors, where joy meets financial prosperity in the world of entertainment."#amusementparks #thrills #rides #familytime #profitable #investment@nasdaq $DIS $SEAS $SIX $FUN $GDHG pic.twitter.com/zLbbts4EFa
— Golden Heaven Group Holdings Ltd. (@GoldenHeavenLTD) March 26, 2024
$GVH $1.46 New HOD On ASK AT $1.51 #Trending #nasdaqs $GVH @Nasdaq huge potential! With its market leadership, experienced leadership team, innovative solutions, strong financial performance, GVH presents a compelling investment opportunity for those seeking exposure to the dynamic e-commerce logistics sector https://axecapitalusa.com/gvh/
$NRXP Stock Dividend & Share Structure Reduction to Counter Short Selling and Boost Institutional Investment: NASDAQ: NRXP https://www.einpresswire.com/article/698768652/stock-dividend-share-structure-reduction-to-counter-short-selling-and-boost-institutional-investment-nasdaq-nrxp via @ein_news $RENB $GVH $GDHG
$GDHG $0.53 0.0303 (6.01%) Pre-Market! "We are honored to be part of this major project with BESTAR as we expand into the Indonesia Market"
For more information, please visit the Company's website at https://ir.jsyoule.com
#amusementparks #nasdaq #investment #expansion
$GDHG $DIS $SEAS $SIX $FUN $CMCSA
$GDHG - "We are honored to be part of this major project with BESTAR as we expand into the Indonesia Market"
— Golden Heaven Group Holdings Ltd. (@GoldenHeavenLTD) March 26, 2024
For more information, please visit the Company's website at https://t.co/o6KKIHgysk #amusementparks #nasdaq #investment #expansion$GDHG $DIS $SEAS $SIX $FUN $CMCSA pic.twitter.com/TvqKoEDjqD
$GDHG - Agreement with Leading Cultural & Artistic Company; Expansion into Indonesia with 30-50 New Amusement Parks: NASDAQ GDHG
@GoldenHeavenLTD
https://einpresswire.com/article/697084490/agreement-with-leading-cultural-artistic-company-expansion-into-indonesia-with-30-50-new-amusement-parks-nasdaq-gdhg via
@ein_news
For more information on $GDHG visit: https://ir.jsyoule.com and https://axecapitalusa.com/gdhg/ $RENB
$NRXP @NRxPharma Planned Public Stock Dividend, Royalty Rights Pledged to Shareholders for Valuable Ketamine Franchise: NASDAQ: NRXP https://www.einpresswire.com/article/696916460/planned-public-stock-dividend-royalty-rights-pledged-to-shareholders-for-valuable-ketamine-franchise-nasdaq-nrxp via @ein_news For more information on $NRXP visit: https://www.nrxpharma.com/ and https://axecapitalusa.com/nrxp/ $GDHG $RENB $KULR
NASDAQ: $GDHG $NRXP $RENB -Sending the Bears back into Hibernation with these 3 potential Short Squeeze Stocks
https://www.einpresswire.com/article/696925899/sending-the-bears-back-into-hibernation-with-these-3-potential-short-squeeze-nasdaq-stocks via @ein_news
$GDHG - Golden Heaven Group Holdings - "Our goal is to establish our amusement parks as entertainment hubs in local areas while advancing the Company's sustainable development and profit objectives." #amusementparks #profitable #investment
@nasdaq $DIS $SEAS $SIX $FUN $GDHG
GDHG - Golden Heaven Group Holdings
— Golden Heaven Group Holdings Ltd. (@GoldenHeavenLTD) March 25, 2024
"Our goal is to establish our amusement parks as entertainment hubs in local areas while advancing the Company's sustainable development and profit objectives." #amusementparks #profitable #investment @nasdaq $DIS $SEAS $SIX $FUN $GDHG pic.twitter.com/7tKAEDMkrK
$NRXP News: NRx Pharmaceutical's (NASDAQ:NRXP) Chairman Dr. Jonathan Javitt to Present at the Ketamine 2024 Conference in Oxford, UK
PR Newswire
Mon, Mar 25, 2024, 8:30 AM EDT5 min read
In This Article:
NRXP
+10.87%
NRXPW
0.00%
RADNOR, Pa., March 25, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that Dr. Jonathan Javitt, Chairman and Chief Scientist of NRx Pharmaceuticals and co-CEO of HOPE Therapeutics, will present at the Ketamine 2024 Conference, which is planned for March 25-27, 2024, at the Blavatnik School of Government in Oxford, UK.
The Ketamine 2024 Conference assembles many of the top scientists and clinicians in the field from around the world and is a forum for top researchers and experienced and interested clinicians to learn from each other about the therapeutic use of Ketamine and related compounds for affective disorders.
Dr. Javitt will present a keynote talk titled, "Ketamine: the Efficacy is Clear, Approval is Critical, and the Risks Must be Balanced." He will present an overview of the rapid and dramatic efficacy of Ketamine in the treatment of acute suicidality as well as recent science documenting the potential for neurotoxicity with long-term CNS side effects if ketamine is used without appropriate safety controls as a long-term drug.
"HOPE Therapeutics builds upon four decades of scientific discovery related to the role of the brain's NMDA receptor and the effects of ketamine and other NMDA-antagonist drugs in rapidly attenuating symptoms of depression and suicidality. It is an honor for our company to be invited to share a platform with those who have established this field of science and who may forever change the outlook and future path of patients who suffer from suicidal depression and PTSD," said Dr. Javitt.
Ketamine 2024 Conference Presentation
When: Monday, March 25th, 2024
Time: 1:40-2:00 PM GMT
Title: Ketamine: The Efficacy is Clear, Approval is Critical, and the Risks Must be Balanced
About NRx Pharmaceuticals
NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx has partnered with Alvogen and Lotus around the development and marketing of NRX-101 for the treatment of suicidal bipolar depression. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.
NRx has recently announced plans to submit a New Drug Application for HTX-100 (IV ketamine), through Hope Therapeutics, in the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.
About HOPE Therapeutics, Inc.
HOPE Therapeutics, Inc. (www.hopetherapeutics.com) is a Specialty Pharmaceutical Company, wholly-owned by NRX Pharmaceuticals focused on development and marketing of an FDA-approved form of intravenous ketamine for the treatment of acute suicidality and depression together with a digital therapeutic-enabled platform designed to augment and preserve the clinical benefit of NMDA-targeted drug therapy.
Notice Regarding Forward-Looking Statements
The information contained herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These statements include, among others, statements regarding the proposed public offering and the timing and the use of the proceeds from the offering. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. Except as may be required by applicable law, The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, whether as a result of new information, future events or otherwise.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaqnrxp-chairman-dr-jonathan-javitt-to-present-at-the-ketamine-2024-conference-in-oxford-uk-302097763.html
SOURCE NRx Pharmaceuticals, Inc.
$IVDN: Our top performing Insultex House Wrap (TM) can help qualify homeowners for significant tax credits under the Inflation Reduction Act. Patented evacuated cell technology optimizes energy efficiency for both heating & cooling. Learn more at: http://insultexhousewrap.com
$IVDN: Our top performing Insultex House Wrap (TM) can help qualify homeowners for significant tax credits under the Inflation Reduction Act. Patented evacuated cell technology optimizes energy efficiency for both heating & cooling. Learn more at: https://t.co/LWNDwJcXDh https://t.co/FeOCVz1Qij
— Innovative Designs, Inc (Stock: $IVDN) (@riccelli_joseph) March 23, 2024
$GVH Technical analysis and chart 5 Day Performance +48.98% #bullish #buynow @nasdaq https://pbs.twimg.com/media/GJNbXBOWkAAYs7Q?format=jpg&name=medium
$MSFT $HOOD $FSR $DKS $PATH $LAC $UA $S $UAA $SOUN $APM $X $CMG $WIMI $CCTG $SOFI $BUD $RIVN $PWDY $SPY $QQQ $AMZN $CWIF $BOME $TPHS $GOEV $IGPK $GMRX
$NRXP News: NRx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 28, 2024
PR Newswire
Thu, Mar 21, 2024, 4:02 PM EDT2 min read
In This Article:
NRXP
+12.29%
RADNOR, Pa., March 21, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it will release its fourth quarter and full year 2023 financial results after the market closes on Thursday, March 28, 2024, via press release, which will be available on the Company's website at https://ir.nrxpharma.com/press-releases. The Company will host a conference call to discuss the financial results as well as provide a corporate update at 4:30 p.m. ET the same day.
A live webcast of the conference call will be available on the Company's website at https://ir.nrxpharma.com/events. Participants that are unable to join the webcast can access the conference call via telephone by dialing domestically 1-877-704-4453, Int'l Investors Dial 1-201-389-0920.
About NRx Pharmaceuticals
NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx has partnered with Alvogen and Lotus around the development and marketing of NRX-101 for the treatment of suicidal bipolar depression. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.
NRx has recently announced plans to submit a New Drug Application for HTX-100 (IV ketamine), through Hope Therapeutics, in the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-to-report-fourth-quarter-and-full-year-2023-financial-results-and-provide-a-corporate-update-on-march-28-2024-302096432.html
$IVDN 's OTCQB certification makes it a member of the OTCQB® Venture Market for entrepreneurial and development stage U.S. and international companies. To be eligible, companies must be current in their reporting and undergo an annual verification and management certification process. #highertier
https://www.otcmarkets.com/otcapi/company/financial-report/394210/content
$GDHG "Our track record speaks for itself, Our successful #NASDAQ listing to the trial operation of Seven Rainbow Park, each milestone underscores our d+edication to creating value. Our portfolio and strategic focus is broadening our presence in the market." https://ir.jsyoule.com/ $GDHG $DIS $SEAS $SIX $FUN $CMCSA
#value #profitability #investors #amusementparks #nasdaq #milestones
GDHG -Our track record speaks for itself, Our successful #NASDAQ listing to the trial operation of Seven Rainbow Park, each milestone underscores our dedication to creating value. Our portfolio and strategic focus is broadening our presence in the market. https://t.co/o6KKIHgysk pic.twitter.com/I2qHZM1pco
— Golden Heaven Group Holdings Ltd. (@GoldenHeavenLTD) March 12, 2024
$NRXP .5873 +16.27% some of these major players squeezing! Great article here: "NASDAQ: $GDHG $NRXP $RENB -Sending the Bears back into Hibernation with these 3 potential Short Squeeze Stocks"
https://www.einpresswire.com/article/696925899/sending-the-bears-back-into-hibernation-with-these-3-potential-short-squeeze-nasdaq-stocks via @ein_news
$AVRW The patent-pending deep nano actives in DNA Complex encapsulates a proprietary blend of anti-aging ingredients that are carried far beneath the layers of the skin. @avenirwellness @sera_labs https://seralabshealth.com/pages/introducing-dna-complex #OTCQB
$IVDN Specifier Magazine has profiled new building code requirements for Continuous Insulation. Innovative Designs' Insultex® meets these new codes where competitive products do not.
Insultex® also delivers an unmatched R-6 Rating. https://insultexhousewrap.com
$RENB $2.85 (Nasdaq) GEDiCube’s award-winning AI is developing high-performance biomarker panels for 13 different cancers. GEDiCube’s partnership with NVIDIA’s Inception program will help expand to multi-modal capabilities by adding imaging. https://renovarobio.com/news/gedicube-and-cyclomics-sign-binding-loi-to-join-forces/ $NVDA $AI #AI
$NRXP Friday's Open @.56 10.87% #bullish #shortsqueeze
$GDHG - Golden Heaven Group Holdings Ltd. is not just building amusement parks; we're crafting experiences that resonate with families across China and now into Indonesia, making investment in our company a gateway to both joyful memories and robust financial growth.
@Nasdaq $GDHG https://axecapitalusa.com/gdhg/
GDHG - Golden Heaven Group Holdings Ltd. is not just building amusement parks; we're crafting experiences that resonate with families across China and now into Indonesia, making investment in our company a gateway to both joyful memories and robust financial growth. @Nasdaq $GDHG pic.twitter.com/yBiMauo8KA
— Golden Heaven Group Holdings Ltd. (@GoldenHeavenLTD) March 22, 2024
$NRXP -NRX100 represents a beacon of light in the darkness of despair. NRX-100 starts sales this month and is expected to turn NRx Pharmaceuticals (through its HOPE subsidiary) into a revenue-generating company in 2024! Key Overview https://axecapitalusa.com/nrxp/ $CBD $GIS
Followers
|
117
|
Posters
|
|
Posts (Today)
|
2
|
Posts (Total)
|
38153
|
Created
|
07/31/17
|
Type
|
Free
|
Moderator jedijazz | |||
Assistants ProfitScout paytheask budfoxfun FrontPageStocks |
FRONT PAGE STOCKS BOARD
Company Profiles:
Shareholder-Friendly Moves Returns 4 Million Shares of Preferred Stock to Company, Plus Equity Partnership with Coastal Spritz Brand and New Business Plans Focused on Real…
Advanced Thin Film Solar Power Technology Used in Aerospace and by NASA, Industrial/Commercial Construction and Many Consumer Goods; Reaching Record Power Generation Milestones: Ascent Solar…
Increasingly Positive Fundamentals Reported for Marketerof Best Performing Skin Care Line with Endorsements by Nicole Kidman and Top Plastic Surgeon: Avenir Wellness Solutions, Inc. (Stock…
New European Supply Chain Center to Enhance Global Growth of Interconnected Products Needed in a Wide Range of Industries: CCSC Technology International Holdings Limited (Nasdaq:…
Clinical Trials Commenced for Promising Acclaim-3 Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer: Genprex, Inc. (NASDAQ: GNPX)GNPX in combination…
Expanding Prospects Ahead for Nicaragua Imported Handmade Premium Cigar Business Backed by Strong Family History and Experience: Green Leaf Innovations, Inc (Stock Symbol: GRLF).For additional…
Cross-Licensing Agreement with I4F to Expand Business Strategies for 3D Printed Ecosystem Flooring and Wall Pannel Products Made with Recycled Ocean Plastics: Northann Corp (NYSE:…
Trial Endpoint Reached for First Suicidal Bipolar Depression, Chronic Pain and PTSD Drug; Agreement with Partners Can Provide up to $329 Million and Royalties: NRx…
Trailblazing AI Driven Early Cancer Diagnostics and Therapeutics for Detection with Nvidia Super Computing Power; Acquiring100% Ownership of Cyclomics; Renovaro Inc. (Nasdaq: RENB)$RENB is Working…
AI Education Provider Plans for New Facilities and Enters Agreement with Top 500 Company in China to Establish Life Sciences Conglomerate in Toronto: Visionary Holdings…
Establish Life Sciences Conglomerate in Toronto: Visionary Holdings…
We believe in building long lasting relationships as noted by our vast amount of real, contactable clients hat span over 2 decades!
This helps individual investors to investigate compelling investments.
We are a link between small public companies and the investing public. The company’s plans, profiles and information are written with the individual investor in mind.
Our goal is to explain the complex, reduce the jargon, and provide a clear and engaging story of each company’s strategy and growth potential.
Bringing you this information requires our staff to work closely with each featured company, as we are small cap stock investors ourselves.
We want what you want – an understanding of what the company does, how they make money and how they intend to grow with frequent company updates.
Small cap investing is unlike buying shares of an S&P 500 company. It is generally a longer term commitment that generates an emotional link with the company.
An understanding of opportunity and the company plan generate the interest. Continued updates and information provide the basis for a satisfied and supportive investor base.
Here at Front Page Stocks, we understand that relationship ultimately closing the gap between investor and company.
We promise to present to you engaging, real companies with real products and services. We hope they will captivate and excite you in return.
Posts Today
|
2
|
Posts (Total)
|
38153
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |